PF-Atlas › Clinical Trials › NCT01086839

Sino-nasal Inhalation of Sodium Chloride 6,0% in Patients With Cystic Fibrosis and Chronic Rhinosinusitis

sodium chloride 6% · Not specified

Registry ID
NCT01086839
Phase
Not specified
Status
Completed
Drug / intervention
sodium chloride 6%
Sponsor
University of Jena
Start
2010-03

About this trial

sodium chloride 6% is evaluated in NCT01086839, a idiopathic pulmonary fibrosis study sponsored by University of Jena. Current status: Completed.

View NCT01086839 on ClinicalTrials.gov →

Medical disclaimer. This page summarizes public trial data for NCT01086839 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.